Difference between revisions of "Feuring-Buske M, et al. Blood (2001) cited as Ref 53 in DOI: 10.1038/s41392-020-0110-5 (Q9316)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 97, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progmetabolism cell growth and tumorigenesisenitor cells from patients with acute myeloid leukemia, #quickstatement...) |
||
| Property / title | |||
| + | Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progmetabolism cell growth and tumorigenesisenitor cells from patients with acute myeloid leukemia (English) | ||
| Property / title: Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progmetabolism cell growth and tumorigenesisenitor cells from patients with acute myeloid leukemia (English) / rank | |||
| + | Normal rank | ||
Revision as of 21:50, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Feuring-Buske M, et al. Blood (2001) cited as Ref 53 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Feuring-Buske M
0 references
Hogge DE
0 references
2001
0 references
Blood
0 references
97
0 references
Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(-) progmetabolism cell growth and tumorigenesisenitor cells from patients with acute myeloid leukemia (English)
0 references
